Amgen was looking into buying more small-sized but profitable firms after its successful bid with Onyx Pharmaceuticals.
Healthcare Health/Fitness
Akorn Inc. to purchase Hi-Tech Pharmacal Co.
Today, Akorn Inc. and Hi-Tech Pharmacal Co. announced they had signed a definitive acquisition agreement valued USD640 million in cash.
Akorn says it will purchase rival for USD 640 million
Generic eye drug manufacturer Akorn said that it would be buying Hi-Tech Pharmacal Co Inc in a deal worth USD 640 million.
AstraZeneca announces another M&A with Amplimmune
AstraZeneca has been looking at another acquisition deal even after spending almost USD1 billion in acquisitions earlier this year.
Vestagen Technical Textiles closes USD 8.25 million in financing
Vestagen Technical Textiles was able to raise USD 8.25 million for the commercial launch of its scrub uniforms.
Latest News
Amgen acquires Onyx Pharmaceuticals for $10.4 billion. Declining sales of its flagship product pushed Amgen to a $10. 4 billion purchase of Onyx Pharmaceuticals, concluding the two-month-long auction of Onyx.
Amgen Inc. might announced the agreement to acquire Onyx Pharmaceuticals Inc. for USD 125 per share piece as soon as Monday.
Sources said KKR agreed to buy 63% in Australian healthcare operator GenesisCare. Sources told Reuters that private equity firm Kohlberg Kravis Roberts & Co (KKR) had approved a stake purchase in GenesisCare.
Sources said that the most likely bidders for Panasonic’s healthcare unit are KKK, Toshiba Corp and a consortium led by Bain Capital.
Regenerative tissue engineering firm TissueTech Inc closed its latest round with USD 10 million. TissueTech Inc successfully closed its latest fundraising round.
Medical device maker Infraredx Inc said it received a USD 25 million equity investment from Nipro Corp.
MicuRx Pharmaceuticals Inc announced the successful closing of its Series B round with USD 25 million.
BioReference Laboratories made known its definitive agreement for the acquisition of BioSystems CLIA,
Life Technologies Corp members of the board approved through voting the company's merger with Thermo Fisher Scientific.
